Ozone Pharmaceuticals Limited, a active public limited company, was established on 13 March 1991 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U99999DL1991PLC043461. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹7.50 Cr and a paid-up capital of ₹5.36 Cr.
Formerly known as Ozone Export India Private Limited, Ozone Pharmaceuticals Private Limited. It upholds a compliant status. Employing 2,164 professional, Its leadership includes Geeta Sehgal (Director), Anju Bala (Director), Akarsh Kashyap (Director). Past directors included Geeta Sehgal, Vinod Kapur, Devender Dogra. It holds ₹94.71 Cr open charges and ₹59.22 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1, Lsc, Block, A-3, Janakpuri, New Delhi, Delhi, 110058.
U99999DL1991PLC043461
043461
13 March 1991
₹7.50 Cr
₹5.36 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Ozone Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Geeta Sehgal | Director | 30 Dec 2009 | Current |
| Anju Bala | Director | 21 Sep 2022 | Current |
| Akarsh Kashyap | Director | 19 Oct 2015 | Current |
| Dipak Kumar Singh | Director | 01 Feb 2016 | Current |
| Anupam Verma | Whole-Time Director | 01 Feb 2021 | Current |
| Subhash Chander Sehgal | Managing Director | 21 Jun 1996 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 29 Dec 2014 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Director | 09 Apr 2015 | Past |
| Pramod Abcsdd | Director | 24 Jul 2020 | Past |
| Pramod Abcsdd | Cfo(Kmp) | 18 Apr 2019 | Past |
| Pramod Abcsdd | Director | 11 Apr 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ozone Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.8% increase. The company also saw a substantial fall in profitability, with a 69.73% decrease in profit. The company's net worth moved up by a moderate rise of 1.65%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Ozone Pharmaceuticals had a promoter holding of 93.30% and a public holding of 6.70%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹947,079,000.00
₹592,214,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Nov 2024 | Others | ₹6.85 Cr | Open |
| 14 Jun 2024 | Hdfc Bank Limited | ₹3.10 M | Open |
| 08 Feb 2024 | Hdfc Bank Limited | ₹1.29 Cr | Open |
| 29 Nov 2023 | Axis Bank Limited | ₹7.65 M | Open |
| 04 Sep 2023 | Yes Bank Limited | ₹25.00 Cr | Open |
Explore comprehensive loan charge details -
Ozone Pharmaceuticals has a workforce of 2164 employees as of Mar 20, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ozone Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ozone Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Surender Pal Mahi was appointed as a Additional Director was appointed as a Additional Director on 26 May 2025 & has been associated with this company since 6 months 7 days . was completed.
A charge with Hdfc Bank Limited of Rs. 32.00 Cr registered on 28 Feb 2022 with Charge ID 100559714 was modified on 30 Jan 2025. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 6.85 Cr with Charge ID 101007173 was registered on 22 Nov 2024. was documented.
Ozone Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on A charge with Yes Bank Limited of Rs. 25.00 Cr registered on 04 Sep 2023 with Charge ID 100837879 was modified on 20 Sep 2024. was documented.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.31 Cr with Charge ID 100967361 was registered on 14 Jun 2024. was documented.
Ozone Pharma wants to make big money, so they launched Molecule thingy to be top pain company. They wanna be top 20 in India too. #Goals #PainFree #MoneyMoves.
The CIN of Ozone Pharmaceuticals Limited is U99999DL1991PLC043461.
Ozone Pharmaceuticals Limited is headquartered at 1, Lsc, Block, A-3, Janakpuri, New Delhi, Delhi, 110058.
Ozone Pharmaceuticals Limited was incorporated on 13 March 1991.
The current directors of Ozone Pharmaceuticals Limited are
The primary industry of Ozone Pharmaceuticals Limited is Manufacturing.
Ozone Pharmaceuticals Limited is unlisted.
The authorized capital of Ozone Pharmaceuticals Limited is ₹7.50 Cr, and the paid-up capital is ₹5.36 Cr.
The compliance status of Ozone Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX